T cells subtypes in a patient with interferon-α induced sarcoidosis

American Journal of the Medical Sciences

Volumn 337, Issue 1, 2009, Pages 60-62

  Monsuez, Jean Jacques ^a   Carcelain, Guislaine ^c   Charniot, Jean Christophe ^a   Barrière, Jérôme ^a   Duclos Vallée, Jean Charles ^b   Parent, Florence ^a   Autran, Brigitte ^c  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

Author keywords

Hepatitis C; Interferon ; Lymphocytes; Sarcoidosis

Indexed keywords

CD28 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2; PEGINTERFERON ALPHA; RIBAVIRIN; ALPHA INTERFERON; ANTIVIRUS AGENT;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CHRONIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; ERYTHEMA NODOSUM; FEMALE; FEVER; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LUNG ALVEOLITIS; LUNG LAVAGE; LUNG SARCOIDOSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; SARCOIDOSIS;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; MIDDLE AGED; SARCOIDOSIS; T-LYMPHOCYTE SUBSETS;

EID: 62249105999     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAJ.0000308932.93221.68     Document Type: Article

References (11)

1. Ramos-Casals M, Mana J, Nardi N, et al. Sarcoidosis in patients with chronic hepatitis C virus infection. Analysis of 68 cases. Medicine 2005;84:69-80.
2. Goldberg HJ, Fiedler D, Webb A, et al. Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir Med 2006;100:2063-2068 (Pubitemid 44514945)
3. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003; 361:1111-1118
4. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006;203:359-370 (Pubitemid 43290845)
5. - T cells are expanded in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22: 13-19
6. +T cells in sarcoidosis patients. Eur Respir J 2005;26:77-85.
7. Gerli R, Schillacci G, Giordano A, et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004;109:2744-2748 (Pubitemid 38737922)
8. Menon Y, Cucurull E, Reisin E, et al. Interferon-alpha-associated sarcoidosis responsive to infliximab therapy. Am J Med Sci 2004;328: 173-175 (Pubitemid 39295865)
9. O'Shea FD, Marras TK, Inman RD. Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum 2006;55:978-981
10. Gonzalez-Lopez MA, Blanco R, Gonzalez-Vela MC, et al. Development of sarcoidosis during etanercept therapy. Arthritis Rheum 2006; 55:817-820
11. Utz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 2003;124: 177-185 (Pubitemid 36851350)